Treatment of vitamin C might make up for the deficiency of SVCT2, thus restoring 5hmC levels via activating TET activity, and inducing apoptosis in breast cancer cells (Sant et al., 2018). The gene discussed is SLC23A2; the disease is breast carcinoma.